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a b s t r a c t
Serotyping of Shiga toxin-producing Escherichia coli (STEC) has been contingent upon the availability of antisera.
Here we describe a 7-plex microbead-based immunoassay to simultaneously serotype seven STECs (i.e., belonging to serogroups O26, O45, O103, O111, O121, O145, and O157) by the Luminex xMAP® technology. This technology presents many advantages: Its multiplexed format (up to 100 analytes) saves time, reagents, and test
sample, and many regulatory agencies currently utilize this platform for other assays. In this study, a total of
seventy-nine STEC strains belonging to the 7 different serogroups of interest were tested. These strains had
been previously serotyped and their serogroup was conﬁrmed by PCR. Except for one strain belonging to the
O111 serogroup, nearly all strains (i.e., 98.7%; 78/79) were correctly identiﬁed on the Bio-Plex 100 instrument
in less than 4 h. This newly developed microbead-based immunoassay could be extended to include other
STEC serogroups, virulence factors, and/or bacterial species.
Published by Elsevier B.V.

1. Introduction
Since the active surveillance of non-O157 STEC was implemented in
the United States in 2001 (CDC, 2012), there has been an increase in
number of reported cases of serotypes other than O157 mostly in part
due to enhanced testing for the presence of Shiga toxin (Stx) in outbreak
related strains (Hurd, 2007). Currently non-O157 infections account for
approximately 50% of all conﬁrmed STEC cases in Europe and in the
United States they out number reported O157 cases (Bosilevac and
Koohmaraie, 2011). Yet, the most virulent serotype commonly isolated
in outbreaks in North America is Escherichia coli O157:H7, and is associated with bloody diarrhea, hemorrhagic colitis (HC), hemorrhagic uremic syndrome (HUS), and thrombotic thrombocytopenic purpura
(Brooks et al., 2005; Willshaw et al., 2000). However, the last 10 years
have produced an increasing number of outbreaks in the United States
attributed to non-O157 STEC which can elicit infections and diseases
similar to E. coli O157:H7 (Anonymous, 1995; Banatvala et al., 1996;
Tarr et al., 1996; Fey et al., 2000; Brooks et al., 2004). It is estimated
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that 96,534 infections are caused by E. coli O157:H7, annually in the
United States while non-O157 STECs serotypes cause 168,698 infections
(Scallan et al., 2011). Approximately 20–50% of worldwide STEC infections are caused by non-O157 serotypes; incidence varies depending
on geographical topology as well as climate conditions (Johnson et al.,
2006; Nataro and Kaper, 1998) Cattle represent the prime reservoir of
STEC strains, exhibiting a particularly high prevalence of non-O157
STEC strains (Bettelheim, 2001). The top six non-O157 STEC serogroups
most commonly implicated in illnesses are O26, O111, O103, O121, O45,
and O145 (Atkinson et al., 2006; Brooks et al., 2005; Gyles, 2006). STECs
causes human illness by expressing at least one Shiga toxin gene (Stx)
consisting of two forms; Stx1 and Stx2. Between these two isoforms,
Stx2 exhibits higher virulence. Its variants are associated with an enhanced probability of HC and HUS (Beutin et al., 2008). Not all
non-O157 STECs will cause human illness, therefore developing a
rapid and highly sensitive method for identiﬁcation of non-O157 STEC
capable of pathogenesis would be of great beneﬁt for regulatory agencies as well as in clinical medicine (Bettelheim, 2007).
We have developed a 7-plex microbead-based immunoassay to allow
simultaneous serotyping of STEC strains belonging to serogroups O26,
O45, O103, O111, O121, O145, and O157 by the Luminex xMAP® technology. Polyclonal antibodies that bind each bacterial serogroup were
conjugated to microbeads used by the Luminex platform, thus allowing
the identiﬁcation of speciﬁc pathogenic bacteria. We tested the speciﬁcity
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of our 7-plex microbead-based immunoassay against a collection of 79
PCR typed E. coli strains belonging to the top 7 E. coli. Such an immunoassay presents signiﬁcant advantages. The 96-well format allows high
throughput, while the multiplexed format (up to 100 analytes) saves
time, reagents, and test samples. Conventional serotyping methods for
identiﬁcation of non-O157 STECs are reliable forms of classiﬁcation, but
can be laborious as well as time consuming often requiring skilled technicians having access to sufﬁcient high quality H antisera, which are
mostly available in a few reference laboratories worldwide (Machado
et al., 2000). Many afﬁliated Food Safety and Inspection Service (FSIS),
Food and Drug Administration (FDA), and Food Emergency Response
Network (FERN) laboratories currently utilize the Luminex platform for
other assays, and our immunoassay would be directly transferable and
could be implemented by these laboratories.

Table 1
STEC strains tested by the 7-plex microbead-based immunoassay.
O
Strain
O
Strain
serogroup identiﬁcation serogroup identiﬁcation
O26

O45

2. Materials and methods
2.1. Antibodies
The antibodies used in this study were previously described
(Olsson-Allen et al., 2011; Hegde et al., 2012). These were prepared
and puriﬁed by SDIX using proprietary methods. Several antibodies
(goat anti-E. coli O26, O45, O103, O111, O121, O145, and O157; rabbit
anti-E. coli O26, O45, O103, O111, O121, O145, and O157; and mouse
anti-E. coli O157) were screened against one representative strain of
each serogroup by indirect then by microplate sandwich ELISA, using
a checkerboard strategy to determine the optimized concentrations of
both capture and detector antibodies (data not shown). Except for
O45, O145 and O157, the capture antibodies with the highest signal to
noise ratio were from goats (data not shown). The best capture antibodies for O45 and O145 were from rabbit samples, and the ones chosen for O157 were of murine origin. Except for the capture antibodies
for O157 which were used at a concentration of 50 μg/mL, all antibodies
were used at a concentration of 5 μg/mL. Except for O157, the same antibodies were used for both capture and detection. The best detection
antibodies for O157 were from goat samples. All detection antibodies
were used at concentrations of 1 μg/mL. Detector antibodies were
biotinylated with the EZ-Link Sulfo-NHS-Long Chain-Biotin kit (Pierce,
Rockford, IL), according to the manufacturer's instructions.
2.2. Analytes
E. coli strains (Table 1) were inoculated in 5 mL of brain heart infusion broth (BHIB; Oxoid, Ltd., Basingstoke, UK). Samples were then incubated overnight (15 h) in a shaking incubator (100 rpm) at 37 °C. After
enrichment, the samples were diluted to an OD600 of 0.01 in PBS
(pH 7.4). Samples were tested by our 7-plex microbead-based immunoassay using the Luminex xMAP® technology (q.v.). The STEC strains
used in this study were human and environmental isolates including
the seven serogroups more commonly associated with outbreak of
human illnesses. The serogroups of the strains used were previously
conﬁrmed by PCR (Lin et al., 2011). Appropriate Biosafety Level 2 precautions were used when handling pathogenic E. coli organisms.
2.3. Buffers and reagents
Phosphate-buffered saline (PBS) with a pH of 7.4 was used to prepare
PBS-TB (PBS, 0.02% Tween 20, and 1% bovine serum albumin) and PBS-T
(PBS and 0.1% Tween 20) that were used for washes. Reagent-grade
chemicals (i.e., 2,29-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
[ABTS], H2O2, KCl, Na3 citrate, NaCl, and Tween 20) were purchased
from Sigma Chemical Co. (St Louis, MO); immunoglobulin (Ig) G-free,
protease-free bovine serum albumin from Jackson ImmunoResearch
(West Grove, PA); streptavidin labeled with R-phycoerythrin from
Invitrogen (Carlsbad, CA); and streptavidin-horseradish peroxidase conjugate from Zymed (San Francisco, CA).
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O103

H19a
DEC10Ba
DEC10Ca
DEC9Fa
TB285Ca
VP30a
TB285Aa
TB352Aa
EK29a
97-3250a
TWO7947a
B8026-C1a
B8227-C8a
08-00017b
D88-28058a
DEC11Ca
5431-72a
4309-65a
2566-58a
B8227-C8a
TB154Aa
87-2931a
MT#82a
MT#80a
EK30a
EK31a
EK32a
109-494a
107-226a
PMK5a
RW1372a
RW1374a
DA40a
D55a

O111

O121

O145

O
Strain
serogroup identiﬁcation

CL-37a
O157
DEC8Ba
3007-85a
TB226Aa
928/91a
412/55a
DEC8Ca
C412a
BCL19a
ED-31a
BCL17a
EK35a
3215-99a
DA-18a
88-4110Ha
DA-69a
MT42a
3-524a
F6173a
DA-1a
DA-5a
DA-37a
MT#2a
87-2914a
MT#11a
MT#22a
GS-G5578620a
IHIT0304a
TB269Ca
MT#66a
BCL73a
IH 16a
02-3422a

5343c
5354c
5618c
5718c
6411c
6418c
6448c
6515c
6577c
6613c
6633c
6646c

a
Strains obtained from the STEC center at Michigan State University's National Food
Safety and Toxicology Center, East Lansing, MI.
b
Strain obtained from the Ohio State Department of Agriculture, Reynoldsburg, OH.
c
Strains obtained from the Orange County Public Health Laboratory, Santa Ana, CA.

2.4. Indirect ELISA assay protocol
A representative strain of each E. coli serogroup was diluted to an
OD600 of 0.01 in PBS (pH 7.4). The wells of a 96-well plate (Nunc,
Rochester, NY) were coated with 100 μL of the diluted bacteria and incubated overnight at 4 °C. After removing the bacterial solution, the
plates were washed three times with PBS-T and blocked with 200 μL
of PBS-TB for 1 h at room temperature. After three washes with PBS-T,
100 μL of antibody solutions was added to the plate and incubated for
1 h at room temperature. After three washes with PBS-T, 100 μL of a
1/500 dilution of HRP-conjugated goat anti-rabbit, rabbit anti-goat, or
rabbit anti-mouse polyclonal was added to each well and incubated
for 1 h at room temperature. After three washes with PBS-T, 100 μL of
ABTS (2,29-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid; Sigma
Chemical Co., St Louis, MO)-horseradish peroxidase substrate solution
(Zymed, San Francisco, CA)) was added to each well to detect bound,
conjugated antibodies. This substrate solution (pH 4.2) was made of
0.548 g/L of ABTS and 17.64 g/L of sodium citrate (Sigma Chemical
Co.). A total of 40 μL of 1 M H2O2 was then added to 6 mL of ABTS citrate.
After 15 min of incubation at room temperature, absorbance was read at
405 nm with the Wallac Victor 2 Multilabel Counter (PerkinElmer, Inc.,
Waltham, MA).
2.5. Sandwich ELISA assay protocol
Selected antibodies were previously tested by sandwich ELISA to optimize the assay conditions (i.e., concentrations of capture and detector
antibodies) prior to incorporating those into a 7-plex microbead-based
immunoassay on the Luminex platform for further speciﬁcity testing
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(Bernard et al., 2012). A checkerboard analysis was conducted to assess
which concentrations of capture and detector antibodies worked best.
One hundred microliters of a solution in PBS (pH 7.4) of capture antibodies (i.e., ranging from 0.5 to 2.0 μg/mL) was added to each well of a
96-well plate (Nunc, Rochester, NY) and incubated overnight at 4 °C.
After removing the capture antibody solution, the plates were then
blocked with 200 μL of PBS-TB for 1 h at room temperature. After
three washes with PBS-T, 100 μL of analyte solutions was added to the
plate and incubated for 1 h at room temperature. After three washes
with PBS-T, 100 μL of a 0.5-mg/mL solution in PBS pH 7.4 of detector
antibody (i.e., ranging from 0.125 to 2.0 μg/mL) was added to each
well and incubated for 1 h at room temperature. After three washes
with PBS-T, 100 μL of a 1/5000 dilution of streptavidin-horseradish peroxidase conjugate in PBS-TB was added to each well and incubated for
1 h at room temperature. After three washes with PBS-T, 100 μL of
ABTS-horseradish peroxidase substrate solution was added to each
well to detect bound, conjugated antibody. After 15 min of incubation
at room temperature, absorbance was read at 405 nm with the Wallac
Victor 2 Multilabel Counter (PerkinElmer, Inc., Waltham, MA). The optimal antigen, capture, and detector antibody concentrations were determined by serial dilutions. For all the pairs of antibodies tested, using the
capture antibodies at a concentration of 1 μg/mL and detector antibodies at a concentration of 0.5 μg/mL worked best (data not shown).
2.6. Covalent coupling of antibodies to carboxylated magnetic
Seven different sets of spectrally unique carboxylated Magplex
superparamagnetic microbeads (6.5 mm in diameter; Luminex Corp.,
Austin, TX) were coated with capture antibodies according to the
manufacturer's instructions provided with the Bio-Plex Amine Coupling
Kit (Bio-Rad, Hercules, CA). Bead region numbers 35, 51, 52, 53, 54, 55,
and 56 were used to couple the capture antibodies for O157, O26, O45,
O103, O111, O121, and O145, respectively. Brieﬂy, each antibody was
covalently coupled to a unique set of microbeads (1.25× 106 beads
per 100 μL coupling reaction) in a two-step carbodiimide-coupling
protocol that utilized 50 mg/mL N-hydroxysulfosuccinimide sodium
salt (Pierce Chemicals, Rockford, IL) and 50 mg/mL 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (Pierce Chemicals).
After each reaction, the concentration of the microbead suspension was
determined by a hemacytometer, and the coupled microbeads stored at
2 to 8 °C in the dark. Each coupling reaction was conﬁrmed with
phycoerythrin-labeled specie anti-species IgG antibodies (Invitrogen)
at concentrations ranging from 0.5 to 32 μg/mL (Fig. 1).
2.7. 7-Plex microbead-based immunoassay protocol
The 7-plex microbead-based immunoassays were conducted in
black, 96-well round bottom polystyrene microplates (Corning Costar,
Lowell, MA), according to Luminex protocols (www.luminexcorp.
com). All incubations were for 1 h at room temperature, protected
from light, and shaken at 600 rpm. In brief, a 100-μl aliquot of each
test sample (bacteria diluted in PBS to OD600 0.01) was combined with
5000 microbeads (previously blocked for 30 min in PBS-TB) of each of
the seven speciﬁcities: E. coli O26, O45, O103, O111, O121, O145, and
O157 in a single microplate well. The microbeads were washed from
unbound reaction components three times with PBS-TB using the BioPlex Pro Wash Station (Bio-Rad). Microbeads were then resuspended
in 100 μL of the biotinylated detector antibody cocktail, containing
1 μg/mL of each antibody and the resultant mixture was incubated.
The mixture was then washed three times as described earlier,
resuspended in 100 μL of 4 μg/mL streptavidin labeled with Rphycoerythrin, and the resultant mixture was incubated, washed, and
resuspended in 100 μL of PBS. The samples were analyzed by Bio-Plex
Manager 6.0 standard software (Bio-Rad) with the Luminex 100 ﬂow
analyzer. Data were acquired using the following settings: 50 μL sample
volume, 100 beads per region, 120 s reading, and DD gate 5000–25,000.

Median Fluorescent Intensity
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25000

O26

20000

O45
O103

15000

O111
10000

O121
O145

5000

O157

0
32

16

8

4

2

1

0.5

0

µg/mL Phycoerythrin
Fig. 1. Conﬁrmation of antibody coupling to the Luminex microbeads using phycoerythrin (PE)-labeled anti-species.

The background ﬂuorescence (i.e., blank samples) was measured on
samples containing all immunoassay reagents except the analyte(s) of
interest. In fact, every microbead has an inherent ﬂuorescence because
of the two ﬂuorochromes embedded in each microbead.
2.8. Statistical analysis
For statistical analysis, the threshold for a positive result was deﬁned as a net Median Fluorescent Intensity (MFI) value that was at
least three times greater than the background MFI.
3. Results
3.1. Antibody coupling to microbeads
Once conditions were optimized by sandwich ELISA, the surface area
of a microplate well was compared to the surface area of a microbead in
order to calculate the amount of capture antibodies necessary for coupling. After coupling we used PE-labeled anti-species antibodies (in a
single-plex format) to conﬁrm that the antibodies had been coupled to
the microbeads successfully. In this immunoassay, the background
wells contained the beads, but not the anti-species-PE (i.e., MFIb 30).
In Fig. 1, the high MFI values, ranging from 15,338 for O157 to 23,532.5
for O26, indicated that the antibodies were successfully coupled to the
beads.
3.2. 7-Plex microbead-based immunoassay speciﬁcity
The speciﬁcity of the 7-plex microbead-based immunoassay was
tested by examining 79 STEC strains listed in Table 1, representing
the seven O serogroups included in the assay. The resulting signal to
background ratios is shown in Table 2 with positive samples and standard deviations indicated in bold. Except for one strain belonging to
the O111 serogroup (i.e., BCL-19), all others were correctly identiﬁed.
Thus the recovery of STEC by our newly developed 7-plex
microbead-based immunoassay was 98.7%.
4. Discussion
A recent study by Verstraete et al. (2012) evaluated a method for the
isolation of non-O157 STEC and sorbitol fermenting (SF) E. coli O157 in
food (Possé et al., 2008), where samples were also submitted to a
rapid predictive screening test for virulence genes (stx, eae, and ehxA
[enterohemolysin]). The non-O157 STEC serotypes studied included
O26, O103, O111, O145, non-sorbitol fermenting (NSF) O157, and SF
O157. Food enrichments (i.e., minced beef, raw-milk cheese, and
sprouted seeds) were inoculated with low numbers of bacterial cells of
above mentioned serotypes. Bacterial cells were either non-stressed,
cold stressed or freeze stressed. Of the analyzed serotypes only O111
and SF O157 strains resulted in an increased number of false negatives.
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Table 2
Ranges of the signal to background ratio of O serogroup speciﬁc antibodies.
Target analyte

O26
O45
O103
O111
O121
O145
O157
a

O serogroup speciﬁc antibodies
O26

O45

O103

O111

O121

O145

O157

26.3–56.6
0.8–1.1
0.2–1.3
0.9–1.1
0.7–1.2
0.4–0.7
0.4–0.6

0.3–0.6
21.8–55.0
0.3–1.0
0.8–1.1
0.8–1.0
0.3–0.8
0.3–0.5

0.6–0.7
0.9–1.0
6.9–54.4
0.8–1.0
0.5–1.1
0.5–0.7
0.6–0.8

0.4–0.5
0.9–1.1
0.3–1.1
57.5–60.6a
0.7–1.1
0.4–0.7
0.4–0.7

0.8–1.1
0.7–0.9
0.4–1.0
0.8–1.1
11.6–51.8
0.7–1.0
0.9–1.3

0.5–0.6
0.9–1.0
0.3–1.0
0.9–1.1
0.8–1.1
3.8–61.8
0.5–0.8

0.5–1.0
0.8–1.3
0.5–1.1
0.9–1.1
0.9–1.1
0.6–0.8
49.6–53.2

The strain that could not be correctly identiﬁed (MFI = 1.0 = background) was excluded from the range.

The false negatives could possibly be due to the stressed state of cells.
Typically, stressed cells endure a longer lag-phase before exponential
growth takes place (Jasson et al., 2007), therefore resulting in decreased
growth in broth culture after an overnight incubation. In addition it is
possible that certain serotypes grow more efﬁciently in some broths
than others, and selective components may reduce the growth of target
strains, as could be the case for O111 serogroup (Verstraete et al., 2012).
Classiﬁcation of bacteria is typically done in terms of repeating
chains of their O-antigen, capsular composition, and ﬂagella antigens
(Hitchcock et al., 1986). An important observation is that serotype classiﬁcation involves the type, but not the number, of repeating O-antigen
units. This allows for a level of enhanced variation within a strain of bacteria (Strauss et al., 2009). Strauss et al. (2009) conducted a study in
which 5 E. coli strains that expressed O-antigen were compared to one
another in terms of LPS length by atomic force microscopy. The strains
compared in this study were E. coli O113:H4, O113:H21, O157:H7,
O157:H12, and O157:H16. Out of these strains O113:H21 demonstrated
a signiﬁcantly greater LPS length compared to all other strains while
O157:H7 exhibited the second greatest LPS length. This indicates that
O-antigen exhibits great variability, and suggests a means for enhanced
attachment of E. coli O113 and O157 to human intestinal cells and food
surfaces, such as fresh produce (Manges et al., 2001). Such variation also
explains why the MFI signals in our assay vary from strain to strain, even
among a single serogroup.
Future directions include transferring the assay to the new, portable
MagPix system. This would ultimately give us a portable, reproducible,
and very sensitive assay that is capable of serotyping the top 7 E. coli.
We also plan on developing monoclonal antibodies for those targets,
and adding more antibodies to our 7-plex microbead-based immunoassay such as E. coli O91, O104, and O113 as well as other outer membrane
proteins eliciting pathogenicity by adhering bacteria onto intestinal epithelial cells. Ultimately we would like to perform our microbead-based
immunoassay on the KingFisher automated high throughput platform
and test it in food enrichments.
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